HIV Citations List: June 2023
Literature Citations
1. Versatile Anti-infective Properties of Pyrido- and Dihydropyrido[2,3-d]pyrimidine-based Compounds. Al Nasr, I.S., A. Corona, W.S. Koko, T.A. Khan, R. Ben Said, I. Daoud, S. Rahali, E. Tramontano, R. Schobert, N. Amdouni, and B. Biersack. Bioorganic & Medicinal Chemistry, 2023. 90: 117376. PMID[37336083].
[PubMed]. HIV_06_2023.
2. Bichromonol, a Dimeric Coumarin with anti-HIV Activity from the Stem Bark of Hypericum roeperianum. Fobofou, S.A.T., K. Franke, W. Brandt, A. Manzin, S. Madeddu, G. Serreli, G. Sanna, and L.A. Wessjohann. Natural Product Research, 2023. 37(12): p. 1947-1953. PMID[35959682].
[PubMed]. HIV_06_2023.
3. HIV-1 Inhibiting Peptides Derived from Human Pegivirus 1 Envelope Protein E2: Viral Interference on Peptide and Protein Level. Kirmess, P., R. Hoffmann, T. Ruegamer, A. Rohrhofer, B. Schmidt, and J. Eichler. Journal of Peptide Science, 2022. 28(53): e3445. ISI[000968566400240].
[WOS]. HIV_06_2023.
4. Synthesis and anti-HIV-1 Activity Evaluation of Keggin-type Polyoxometalates with Amino acid as Organic Cations. Tian, N., D. Chu, H. Wang, and H. Yan. Bioorganic & Medicinal Chemistry Letters, 2023. 91: p. 129380. PMID[37331638].
[PubMed]. HIV_06_2023.
5. Exploration of Novel Class anti-HIV-1 Agents Derived from a Viral Capsid Protein. Tsuji, K., R.Y. Wang, B.A.K. Owusu, T. Kobayakawa, T. Murakami, and H. Tamamura. Journal of Peptide Science, 2022. 28(53): e3445. ISI[000968566400108].
[WOS]. HIV_06_2023.
6. Triterpene Constituents from the Fruits of Cyclocarya paliurus and Their Anti-HIV-1IIIB Activity. Tu, W.C., R.H. Luo, E. Yuan, K.J. Sakah, Q.Y. Yang, W.L. Xiao, Y.T. Zheng, and M.F. Liu. Natural Product Research, 2023. 37(11): p. 1787-1796. PMID[36095038].
[PubMed]. HIV_06_2023.
7. Anti-HIV-1 Activity and Mode of Action of pepRF1, a CXCR4 Antagonist Peptide. Veiga, A.S., I. Cadima-Couto, A. Tauzin, J.M. Freire, T.N. Figueira, R.D.M. Silva, C. Perez-Peinado, C. Cunha-Santos, I. Bartolo, N. Taveira, L. Gano, J.D.G. Correia, J. Goncalves, F. Mammano, D. Andreu, and M. Castanho. Journal of Peptide Science, 2022. 28(53): e3445. ISI[000968566400192].
[WOS]. HIV_06_2023.
8. An Artificial Peptide-based Bifunctional HIV-1 Entry Inhibitor That Interferes with Viral Glycoprotein-41 Six-helix Bundle Formation and Antagonizes CCR5 on the Host Cell Membrane. Wang, C., Q. Li, L. Sun, X. Wang, H. Wang, W. Zhang, J. Li, Y. Liu, L. Lu, and S. Jiang. Viruses, 2023. 15(5): 1038. PMID[37243126]. PMID[PMC10223265].
[PubMed]. HIV_06_2023.
9. A dePEGylated Lipopeptide-based Pan-coronavirus Fusion Inhibitor Exhibits Potent and Broad-spectrum Anti-HIV-1 Activity without Eliciting Anti-PEG Antibodies. Xu, L., C. Wang, W. Xu, L. Xing, J. Zhou, J. Pu, M. Fu, L. Lu, S. Jiang, and Q. Wang. International Journal of Molecular Sciences, 2023. 24(11): 9779. PMID[37298729]. PMID[PMC10253554].
[PubMed]. HIV_06_2023.
10. Bisabolane-type Sesquiterpenoids with Potential Anti-inflammatory and anti-HIV Activities from the Stems and Leaves of Morinda citrifolia. Zhao, Y.Y., Y.J. Li, X.M. Yu, Q.T. Su, L.W. Wang, Y.S. Zhu, Y.H. Fu, G.Y. Chen, and Y.P. Liu. Natural Product Research, 2023. 37(12): p. 1961-1968. PMID[35975763].
[PubMed]. HIV_06_2023.
Patent Citations
11. Preparation of Nucleoside Compounds Useful in HIV Therapy. Miller, J.F. and E.J. Velthuisen. Patent. 2023. US2020-865678 20230174534: 144pp.
[Patent]. HIV_06_2023.